Back to search

Peptide record

TPDB13716

Antibacterial standard
37 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB13716
Antibacterial
Anti-infective peptides
AntiBP3 Peptipedia
standard
No
A 37-aa standard natural antibacterial peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
GLLSRLRDFLSDRGRRLGEIIERIGQIIKDLSEFFQS
Physicochemical Analysis
C192H318N58O56
ANCHMPTWYV
RL
4334.99
10.07
7
6
14
+1
9.02
-0.270
115.95
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
6
Residue Composition
number
0
A
6
R
0
N
3
D
0
C
3
E
2
Q
4
G
0
H
5
I
6
L
1
K
0
M
3
F
0
P
4
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 6 N: 0 D: 3 C: 0 E: 3 Q: 2 G: 4 H: 0 I: 5 L: 6 K: 1 M: 0 F: 3 P: 0 S: 4 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
37
C192H318N58O56
4334.99
10.07
+1
9.02
-0.270
Evidence Records 9 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.025 µg/mL

Target

S. aureusATCC25923

Source & Reference

NA

Other

Active against Gram+ S. aureusATCC25923 (MIC 0.025 ug/ml), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21533 (MIC 62.5 ug/ml), B. subti
Evidence 2 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

Staphylococcus epidermidis LY8

Source & Reference

NA

Other

Active against Gram+ S. aureusATCC25923 (MIC 0.025 ug/ml), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21533 (MIC 62.5 ug/ml), B. subtilis CICC24434 (MIC 0.78 ug/ml), Gra
Evidence 3 Activity

Activity

MIC
Antibacterial
62.5 µg/mL

Target

L. monocytogenes CICC21533

Source & Reference

NA

Other

ve against Gram+ S. aureusATCC25923 (MIC 0.025 ug/ml), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21533 (MIC 62.5 ug/ml), B. subtilis CICC24434 (MIC 0.78 ug/ml), Gram- S. choleraesuis C78-1 (MIC 0.78 ug/ml), S.
Evidence 4 Activity

Activity

MIC
Antibacterial
0.78 µg/mL

Target

B. subtilis CICC24434

Source & Reference

NA

Other

5 ug/ml), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21533 (MIC 62.5 ug/ml), B. subtilis CICC24434 (MIC 0.78 ug/ml), Gram- S. choleraesuis C78-1 (MIC 0.78 ug/ml), S. typhimurium SL1344 (MIC 0.78 ug/ml), P.
Evidence 5 Activity

Activity

MIC
Antibacterial
0.78 µg/mL

Target

S. choleraesuis C78-1

Source & Reference

NA

Other

. monocytogenes CICC21533 (MIC 62.5 ug/ml), B. subtilis CICC24434 (MIC 0.78 ug/ml), Gram- S. choleraesuis C78-1 (MIC 0.78 ug/ml), S. typhimurium SL1344 (MIC 0.78 ug/ml), P. avium C48-3 (MIC 1.56 ug/ml), E. coli CICC100
Evidence 6 Activity

Activity

MIC
Antibacterial
0.78 µg/mL

Target

S. typhimurium SL1344

Source & Reference

NA

Other

l), B. subtilis CICC24434 (MIC 0.78 ug/ml), Gram- S. choleraesuis C78-1 (MIC 0.78 ug/ml), S. typhimurium SL1344 (MIC 0.78 ug/ml), P. avium C48-3 (MIC 1.56 ug/ml), E. coli CICC10004 (MIC 12.5 ug/ml), and S. flexneri CIC
Evidence 7 Activity

Activity

MIC
Antibacterial
1.56 µg/mL

Target

P. avium C48-3

Source & Reference

NA

Other

l), Gram- S. choleraesuis C78-1 (MIC 0.78 ug/ml), S. typhimurium SL1344 (MIC 0.78 ug/ml), P. avium C48-3 (MIC 1.56 ug/ml), E. coli CICC10004 (MIC 12.5 ug/ml), and S. flexneri CICC21534 (MIC 50 ug/ml).
Evidence 8 Activity

Activity

MIC
Antibacterial
12.5 µg/mL

Target

Escherichia coli CICC10004

Source & Reference

NA

Other

MIC 0.78 ug/ml), S. typhimurium SL1344 (MIC 0.78 ug/ml), P. avium C48-3 (MIC 1.56 ug/ml), E. coli CICC10004 (MIC 12.5 ug/ml), and S. flexneri CICC21534 (MIC 50 ug/ml).
Evidence 9 Activity

Activity

MIC
Antibacterial
50 µg/mL

Target

S. flexneri CICC21534

Source & Reference

NA

Other

MIC 0.78 ug/ml), P. avium C48-3 (MIC 1.56 ug/ml), E. coli CICC10004 (MIC 12.5 ug/ml), and S. flexneri CICC21534 (MIC 50 ug/ml).